Medical device and MedTech insights, news, tips and more

FDA Moves us Closer to a Surgical Robotic Future

October 19, 2017

Surgery performed by robotic arm- 3D rendering

Much negativity surrounds the public perception of our robot-ridden future. Indeed, sensationalist fears about thousands or millions of jobs undergoing ruthless robotic appropriation spread like wildfire. But the advancement of intelligent machines isn’t all that miserable. Indeed, some advancements presently making waves will save lives. Enter the Senhance System, a surgical robot recently cleared by the U.S. Food and Drug Administration (FDA) for use in minimally-invasive surgeries.

Surgical Robotic

Developed by medical device company TransEnterix, Senhance is a robotically-assisted surgical device (RASD) that lets surgeons use computer and software technology to move and control surgical instruments in procedures involving one or more tiny incisions in a patient’s body. Surgeons operate Senhance through a console unit or cockpit with a 3-D high-definition view of the surgical field, where they remotely control three separate arms, each equipped with a surgical instrument.

MAN AND MACHINE WORKING TOGETHER

Amid rumors of ineluctable robot oppression, it’s easy to assume the robot-human work dynamic would be based on conflict, instead of mutual beneficence. Senhance-based robotic surgery could enhance the survival rate of surgeries that otherwise remain infamously dangerous. “The clearance of the Senhance System in the US is a milestone in the progress of robotics and is expected to deliver improvement in the efficacy, value and choices offered to patients, surgeons and hospitals,” TransEnterix president and CEO Todd M. Pope said in a statement.

Read the Rest at the Source: New FDA Approved Tech Moves Us Closer to a Robotic Future

More insights

October 12, 2023
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Learn More
October 10, 2023
FDA clears Intelivation Technologies new Hammerdesis™ Interphalangeal Fusion System
Learn More
October 9, 2023
FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.